Position
Truepoint, Inc. in AbbVie Inc.
Back to the book · All holders of ABBV
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$12.5K$228.49 → $217.49
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.13K | $259.1K | — | — | — | 0.0% |
| Q1 2026 | 1.29K | $280.3K | $217.49 | −$12.5K | $33.7K | 0.0% |